Asia-Pacific Clinical Trial Supplies Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Published Report
  • Nov 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 72
  • No of Figures: 34

Asia-Pacific Clinical Trial Supplies Market, By Services (Storage, Manufacturing, Packaging and Labelling), Clinical Phases (Phase III, Phase II, Phase IV and Phase I), Therapeutic Uses (Oncology, Cardiovascular Diseases, Dermatology, Metabolic Disorders, Infectious Diseases, Respiratory Diseases, CNS and Mental Disorders, Blood Disorders and Others), End User (Contract Research Organizations and Pharmaceutical and Biotechnology Companies), Countries (China, Japan, South Korea, India, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Clinical Trial Supplies MarketMarket Analysis and Insights : Asia-Pacific Clinical Trial Supplies Market

The clinical trial supplies market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.8% in the forecast period of 2020 to 2027 and is expected to reach USD 4,843.55 million by 2027.

The major factor driving the growth of the clinical trial supplies market are rising of demand in clinical trials worldwide, increasing incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in future.

The clinical trial is a research study that determines whether a medical strategy, treatment, or device is safe, effective and useful for humans use. These studies help in find which medical approaches experiment is best for certain diseases. A clinical trial provides the best data for health care decision-making purposes.

The purpose of clinical trials is to study strict scientific standards. These standards protect patients and help in producing reliable study results. Clinical trials are last stage in drug development in a long and careful research process that is carried out by scientists or researchers for a particular disease, whether drug or medical device. The process drug development often begins in a lab, where scientists first develop and test new ideas related to treatment of disease.

The clinical trial supplies market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, products approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Clinical Trial Supplies MarketClinical Trial Supplies Market Scope and Market Size  

The clinical trial supplies market is categorized based on services, clinical phase, therapeutic uses and end user.

  • On the basis of services, the clinical trial supplies market is segmented into storage, manufacturing, packaging and labelling. In 2020, storage segment in clinical trial supplies market is expected to grow due to direct-to-site shipment approach, as well as mixed alternatives combining central and local depots of clinical supplies in the clinical trial supplies market.
  • On the basis of clinical phases, the clinical trial supplies market is segmented into phase I, phase II, phase III and phase IV. In 2020, phase III segment in clinical trial supplies market is expected to grow because it requires thousands of people to perform experiments and these experiments goes for longer period of time which further needs more supplies and services in various pharma companies and contract research organizations (CROs).
  • On the basis of therapeutic uses, the clinical trial supplies market is segmented into oncology, cardiovascular diseases, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others. In 2020, oncology segment in clinical trial supplies market is expected to grow because of the increasing number of patients with cancer and research on cancer in clinical trials is also rising significantly.
  • On the basis of end user, the clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies. In 2020, contract research organizations segment in clinical trial supplies market is expected to grow because most of the clinical trial experiments performed for medicines such as drugs or medical devices are used for the treatment of diseases by contract research organizations (CROs).

Clinical Trial Supplies Market Country Level Analysis

The clinical trial supplies market is analysed and market size information is provided by services, clinical phases, therapeutic uses and end user as referenced above. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

The countries covered in the market are China, Japan, South Korea, India, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of Asia-Pacific.

China is driving the growth in the Asia-Pacific clinical trial supplies market because of increasing incidences of diseases and government funds to R&D investments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as sales, FDA approvals, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global branded and generic drug manufacturers and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Continuous Advancement in Technological Services is Propelling the Market Growth

The clinical trial supplies market also provides you with detailed market analysis for every country growth in installed base of different kind of products for Clinical Trials Supplies market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the Clinical Trials Supplies market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Clinical Trial Supplies Market Share Analysis

The clinical trial supplies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to clinical trial supplies market.

The major prominent participants operating in the clinical trial supplies market are Movianto, Sharp, Thermo Fisher Scientific Inc., Catalent, Inc, PCI Pharma Services, Almac Group, PAREXEL International Corporation, Bionical Ltd., Alium Medical Limited, MYODERM, Clinigen Group plc and Ancillare, LP, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Clinical Trial Supplies Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018 – 2027, (USD MILLION)

TABLE 2 ASIA-PACIFIC STORAGE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION , 2018-2027 (USD MILLION)

TABLE 3 ASIA-PACIFIC MANUFACTURING CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 ASIA-PACIFIC PACKAGING AND LABELLING CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 ASIA-PACIFIC DISTRIBUTION CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC PHASE III CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC PHASE II CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFIC PHASE IV CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC PHASE I CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC ONCOLOGY CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC CARDIOVASCULAR DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC DERMATOLOGY CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC METABOLIC DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC INFECTIOUS DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC RESPIRATORY DISEASES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC CNS AND MENTAL DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC BLOOD DISORDERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC OTHERS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC CONTRACT RESAERCH ORGANIZATIONS CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 26 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 27 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 28 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 29 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 30 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 31 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 32 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 33 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 34 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 35 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION)

TABLE 36 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 37 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 38 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 39 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 40 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 41 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 42 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 43 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 44 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 45 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 46 ASUTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 47 ASUTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 48 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 49 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 50 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 51 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 52 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 53 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 54 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 55 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 56 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 57 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 58 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 59 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 60 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 61 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 62 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 63 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 64 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 65 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 66 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 67 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 68 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

TABLE 69 REST OF ASIA-PACIFIC ORECLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2018-2027 (USD MILLION )

TABLE 70 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE , 2018-2027 (USD MILLION )

TABLE 71 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE , 2018-2027 (USD MILLION )

TABLE 72 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER , 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions